Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Duchenne
Pharma
Patient dies after receiving Sarepta's DMD gene therapy Elevidys
The incident brings attention to the safety of AAV-based gene therapies and could spark renewed concerns over the benefit-risk profile of Elevidys.
Angus Liu
Mar 18, 2025 10:34am
Lawmakers pressure PTC on Emflaza price
Mar 23, 2017 9:08am
Marathon makes surprise deal to sell Emflaza for $140M-plus
Mar 16, 2017 10:40am
Lawmakers pull FDA into the dock over Marathon's Emflaza nod
Mar 15, 2017 4:51pm
Eight senators pile on to Marathon's $89K Emflaza price tag
Mar 6, 2017 10:30am
Marathon halts launch of DMD drug as $89K price attracts congressional heat
Feb 13, 2017 4:56pm
